WOKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
WORK Medical Technology Group LTD
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 30, 2026
$1.20+0.11 (+10.09%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
WORK Medical Technology statistics
Financials through Sep 30, 2025, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Market Cap | $124.31M | $230.55M |
| Enterprise Value | $129.44M | $202.97M |
| PS Ratio | 12.62 | 3.11 |
| PB Ratio | 6.78 | 3.14 |
| P/TBV Ratio | 7.15 | 4.57 |
| P/FCF Ratio | 25.31 | 27.25 |
| P/OCF Ratio | 19.91 | 22.35 |
Enterprise value
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| EV / Sales | 13.14 | 2.92 |
| EV / EBITDA | 375.56 | 19.86 |
| EV / FCF | 26.35 | 27.85 |
Income (trailing twelve months)
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Revenue | $9.85M | $102.39M |
| Gross Profit | $2.34M | $60.36M |
| Pretax Income | -$1.08M | -$2.26M |
| Net Income | -$1.07M | -$6.57M |
| EBITDA | $344.66K | -$1.98M |
| EPS (Diluted) | -$0.04 | -$0.07 |
Margins
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Gross Margin | 23.8% | 55.1% |
| Pretax Margin | -11.0% | -4.11% |
| Profit Margin | -10.9% | -10.5% |
| EBITDA Margin | 3.50% | -2.67% |
| FCF Margin | 49.9% | -0.30% |
Returns
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -6.81% | -19.2% |
| Return on Assets (ROA) | -3.09% | -13.3% |
Growth
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -14.4% | 8.85% |
| Revenue Growth (3Y CAGR) | -20.6% | 7.08% |
Balance sheet
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.09M | $37.33M |
| Total Debt | $6.39M | $72.66M |
| Net Cash (Debt) | -$2.30M | $3.92M |
| Net Cash Per Share | -$0.02 | $0.28 |
| Equity (Book Value) | $18.34M | $57.36M |
| Book Value Per Share | $0.18 | $2.81 |
| Tangible Book Value | $17.38M | $10.71M |
| Working Capital | $8.48M | $54.64M |
Financial position
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Current Ratio | 1.71 | 2.50 |
| Quick Ratio | 0.39 | 1.54 |
| Debt / Equity | 0.35 | 0.38 |
| Debt / EBITDA | 18.54 | 2.31 |
| Debt / FCF | 1.30 | 3.50 |
| Net Debt / EBITDA | 6.68 | 1.53 |
Cash flow (trailing twelve months)
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Operating Cash Flow | $6.24M | -$653.46K |
| Capital Expenditures | -$1.33M | -$3.69M |
| Free Cash Flow | $4.91M | -$835.02K |
| FCF Per Share | $0.05 | -$0.02 |
Efficiency
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Asset Turnover | 0.28 | 0.59 |
| Inventory Turnover | 2.66 | 2.21 |
| Revenue Per Employee | $214.10K | $322.57K |
| Profits Per Employee | -$23.32K | -$51.88K |
| Employee Count | 46 | 185 |
Dividends and yields
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Earnings Yield | -0.86% | -6.91% |
| FCF Yield | 3.95% | -0.56% |
Shares
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Shares Outstanding | 103,591,000 | 44,856,700 |
| Shares Change (YoY) | 128.1% | 3.35% |
| Float | 103,367,000 | 37,097,900 |
| Shares Held by Insiders | 0.22% | 10.6% |
Taxes
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Income Tax | $119.05K | $1.52M |
Scores
| Measure | WORK Medical Technology | Industry median |
|---|---|---|
| Altman Z-Score | 7.03 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from WORK Medical Technology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.